Categories AlphaGraphs, Earnings, Health Care

Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up 5% year-over-year.

Net income attributable to Gilead was $1 billion, or $0.83 per share, compared to $1.1 billion, or $0.91 per share, last year. Adjusted EPS was $1.34.

For the full year of 2023, GAAP EPS is expected to be $4.50-4.85 while adjusted EPS is estimated to be $6.45-6.80.

Prior performance

Most Popular

Important takeaways from Conagra Brands’ Q4 2025 report

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported weaker-than-expected sales and adjusted earnings for its fourth quarter, reflecting ongoing economic uncertainty and muted consumer spending.

Delta Air Lines (DAL) gains on strong Q2 2025 performance

Shares of Delta Air Lines (NYSE: DAL) rose 12% on Thursday after the company delivered strong results for the second quarter of 2025 and restored its guidance for the full

CAG Earnings: Conagra Brands Q4 adj. profit drops, misses estimates

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported lower sales and adjusted earnings for the fourth quarter of 2025. Results missed analysts' estimates. Net sales

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top